期刊文献+

IL-17在高危型HPV阳性宫颈癌中的表达 被引量:7

The expression of IL-17 in the cervical cancer with high-risk human papillomavirus infection
暂未订购
导出
摘要 目的:通过检测高危型人乳头瘤病毒(HPV)阳性宫颈癌患者体内IL-17的表达水平,探讨IL-17所介导的特异性免疫反应在高危型HPV感染的宫颈癌发生、发展中可能发挥的作用。方法:选取高危型HPV阳性的宫颈浸润性鳞癌患者(宫颈癌组)28例、宫颈高危型HPV感染者(HPV感染组)25例以及对照组30例。采用ELISA法检测各组患者外周血清及宫颈局部组织匀浆上清液中IL-17的表达水平。结果:1宫颈癌组患者外周血清中IL-17水平较对照组明显升高(P<0.05),与HPV感染组比差异无统计学意义(均P>0.05),HPV感染组与对照组间差异无统计学意义(P>0.05);2各组宫颈局部组织匀浆上清液中IL-17的表达水平均明显高于外周血清表达水平,差异均有统计学意义(均P<0.05);3宫颈局部组织匀浆上清液中IL-17表达水平各组间的差异均有统计学意义(均P<0.05),且宫颈癌组局部组织匀浆上清液中IL-17的表达水平高于HPV感染组,HPV感染组高于对照组,差异均有统计学意义(均P<0.05)。结论:IL-17所介导的免疫反应可能参与并促进了高危型HPV的持续性感染,与宫颈癌的发生、发展进程相关。 Objective: To investigate the expression of IL-17 in patients diagnosed as cervical squamous cell carcinoma (SCC) with high-risk human papillomavirus (HPV) infection, with the aim to explore the potential role of specific immune response mediated by IL-17 in the disease progression and carcinogenesis of cervical cancer which is closely associated with high-risk HPV infection. Methods: The study groups included 28 cervical SCC patients with high-risk HPV infection and 25 high-risk HPV infected women with normal cervical cytol- ogy. Thirty patients diagnosed as uterine myoma with normal cervical cytology and negative HPV testing were enrolled as the control group. The concentration of IL-17 in serum and supernatant of cervical tissue homogenate were examined with ELISA method. Results: ①The serum concentrations of IL-17 in patients with cervical SCC were significantly higher than those in the control group (P〈0.05), but there was no significant difference observed between SCC group vs the high-risk HPV infection group (P〉0.05) and the high-risk HPV infection group vs the control group (P〉0.05); ②The average concentrations of IL-17 in supernatant of cervical tissue ho- mogenate of all groups were obviously higher than those in serum respectively (P〈0.05); ③The concentrations of IL-17 in supernatant of cervical tissue homogenate differed significantly among the study groups and the con- trol group (P〈0.05). The concentrations in the cervical SCC group were higher than those in the high-risk HPV infected group, which were much higher than the control group (P〈0.05). Conclusion: These results indicate that the immune reaction mediated by IL-17 may participate in and promote the persistent infection of high-risk HPV, which is closely associated with the disease 19roffression and carcinogenesis of cervical cancer cervical cancer.
出处 《温州医科大学学报》 CAS 2016年第1期24-27,32,共5页 Journal of Wenzhou Medical University
基金 浙江省卫生厅科研基金资助项目(2011KYA107)
关键词 白细胞介素17 宫颈肿瘤 人乳头瘤病毒 IL-17 uterine cervical neoplasms human papillomavirus
  • 相关文献

参考文献15

  • 1FERLAY S H, BRAY F, FORMAN D, et al. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base number 10. Lyon, France: International Agency for Research on Cancer 2010[J]. http://globocan.iarc.fr (ac- cessedAug 10, 2010), 2010.
  • 2ZUR HAUSEN H. Papillomaviruses and cancer: from basic studies to clinical application[J]. Nat Rev Cancer, 2002, 2(5): 342-350.
  • 3潘镏镏,郑飞云,诸海燕,章圣辉,胡燕.鸦胆子素D对HPV16感染细胞株的作用及其可能机制[J].温州医学院学报,2015,45(2):89-94. 被引量:5
  • 4COX J T. Epidemiology and natural history of HPV[J]. J Fam pract, 2006, Suppl: 3-9.
  • 5HARRINGTON L E, Hatton R D, Mangan P R, et al. Inter- leukin 17-producing CD4+ effector T cells develop via a lin- eage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005, 6(11): 1123-1132.
  • 6PARK H, LI Z, YANG X O, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleu- kin 17[J]. Nat Immunol, 2005, 6(11): 1133-1141.
  • 7刘英平,陈扬.宫颈癌患者血清IL-17、VEGF水平检测的临床意义分析[J].中国实验诊断学,2013,17(11):2053-2054. 被引量:6
  • 8DU W J, ZHEN J H, ZENG Z Q, et al. Expression of inter- leukin-17 associated with disease progression and liver fi- brosis with hepatitis B virus infection: IL-17 in HBV infec- tion[J]. Diagn Pathol, 2013, 8: 40.
  • 9YEH C Y, SHUN C T, KUO Y M, et al. Activated human val- vular interstitial cells sustain interlenkin-17 production to re- cruit neutrophils in infective endocarditis[J]. Infect Immun, 2015, 83(6): 2202-2212.
  • 10KARBACH S, CROXFORD A L, OELZE M, et al. Interleu- kin 17 drives vascular inflammation, endothelial dysfunc- tion, and arterial hypertension in psoriasis-like skin disease[J]. Arterioscler Thromb Vasc Biol, 2014, 34(12): 2658- 2668.

二级参考文献23

  • 1牛晓宇,彭芝兰,王和.RNA干涉抑制宫颈癌CaSki细胞株HPV16 E6基因的研究[J].癌症,2004,23(11):1257-1262. 被引量:27
  • 2王萍,崔竹梅,罗兵,林萍.小分子干扰RNA对子宫颈癌细胞中人乳头状瘤病毒18型E6、E7mRNA表达的影响[J].中华妇产科杂志,2006,41(3):190-193. 被引量:7
  • 3冯怡,邓远辉,陈桂容,陈碧芬.鸦胆子抗人乳头瘤病毒的作用研究[J].中成药,2006,28(12):1819-1820. 被引量:19
  • 4Liu JH, Qin JJ, Jin HZ, et al. A new triterpenoid from Bru- cea javanica[J]. Arch Pharm Res, 2009, 32(5): 661-666.
  • 5Pan L, Chin YW, Chai HB, et al. Bioactivity-guided iso- lation of cytotoxic constituents of Brucea javanica collected in Vietnam[J]. Bioorg Med Chem, 2009, 17(6): 2219-2224.
  • 6Yu YL, Lu Y, Tang X, et al. Formulation, preparation and evaluation of an intravenous emulsion containing Brucea ja- vanica oil and Coix Seed oil for anti-tnmor application[J]. Biol Pharm Bull, 2008, 31(4): 673-680.
  • 7de Boer MA, Jordanova ES, Kenter GG, et al. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical can- cer patients [J]. Clin Cancer Res, 2007, 13(1): 132-138.
  • 8Chang JT, Kuo TF, Chen Y J, et al. Highly potent and specif- ic siRNAs against E6 or E7 genes of HPV16-or HPV18- infected cervical cancers[J]. Cancer Gene Ther, 2010, 17 (12): 827-836.
  • 9Munger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus induced oncogenesis[J]. J Virol, 2004, 78(21): 11451-11460.
  • 10尹香菊,栾和芝,安春丽,王雪莲,邴玉艳,王晓娜.鸦胆子油乳对宫颈癌Hela细胞的抑制作用及其作用机制[J].中国肿瘤生物治疗杂志,2008,15(4):393-395. 被引量:28

共引文献9

同被引文献51

  • 1李树军,石太新,唐成和.血管内皮细胞生长因子及其受体与血液系统恶性肿瘤的关系[J].医学综述,2006,12(13):792-795. 被引量:2
  • 2朱雄增.学习和掌握肿瘤的WHO分类,提高病理诊断和研究的水平[J].中华病理学杂志,2006,35(11):646-650. 被引量:14
  • 3谢幸,苟文丽.妇产科学[M].北京:人民卫生出版社,2013:359.
  • 4DIMAIO D, LIAO J B. Human papillomaviruses and cervical cancer [J]. AdvVirusRes, 2006, 66: 125-159.
  • 5WOODMAN C B, COLLINS S I, YOUNG L S. The natural history of cervical HPV infection: unresolved issues [J]. Nat Rev Cancer, 2007, 7 (1): 11-22.
  • 6SHEU B C, CHANG W C, LIN H H, et al. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia [ J]. J Obstet Gynaecol Res, 2007, 33 (2): 103-113.
  • 7DAS P M, SINGAL R. DNA methylation and cancer [ J]. J Clin Oncol, 2004, 22 (22): 4632-4642.
  • 8WILKE C M, KRYCZEK I, WEI S, et al. Th17 cells in cancer: help or hindrance? [J]. Carcinogenesis, 2011, 32 (5): 643 - 649.
  • 9CHERNOV A V, STRONGIN A Y. Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer [ J 1. Biomol Concepts, 2011, 2 (3): 135-147.
  • 10HASHIMOTO K, OTERO M, IMAGAWA K, et al. Regulated transcription of human matrix metalloproteinase 13 ( MMP 13 ) and interleukin- 113 (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites [ J ]. J Biol Chem, 2013, 288 (19): 10061-10072.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部